News Image

Analyzing NYSE:JNJ's Dividend Potential.

By Mill Chart

Last update: Jan 30, 2024

JOHNSON & JOHNSON (NYSE:JNJ) has caught the attention of dividend investors as a stock worth considering. NYSE:JNJ excels in profitability, solvency, and liquidity, all while providing a decent dividend. Let's delve into the details.

Understanding NYSE:JNJ's Dividend

An integral part of ChartMill's stock analysis is the Dividend Rating, which spans from 0 to 10. This rating evaluates diverse dividend factors, including yield, historical data, growth, and sustainability. NYSE:JNJ has received a 7 out of 10:

  • Compared to an average industry Dividend Yield of 4.42, JNJ pays a better dividend. On top of this JNJ pays more dividend than 93.10% of the companies listed in the same industry.
  • JNJ's Dividend Yield is a higher than the S&P500 average which is at 2.47.
  • On average, the dividend of JNJ grows each year by 9.96%, which is quite nice.
  • JNJ has paid a dividend for at least 10 years, which is a reliable track record.
  • JNJ has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
  • 34.25% of the earnings are spent on dividend by JNJ. This is a low number and sustainable payout ratio.

Unpacking NYSE:JNJ's Health Rating

ChartMill employs its own Health Rating for stock assessment. This rating, ranging from 0 to 10, is calculated by examining various liquidity and solvency ratios. In the case of NYSE:JNJ, the assigned 6 reflects its health status:

  • An Altman-Z score of 4.81 indicates that JNJ is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 4.81, JNJ is doing good in the industry, outperforming 79.80% of the companies in the same industry.
  • JNJ has a debt to FCF ratio of 1.90. This is a very positive value and a sign of high solvency as it would only need 1.90 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.90, JNJ belongs to the top of the industry, outperforming 92.12% of the companies in the same industry.
  • JNJ has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
  • Even though the debt/equity ratio score it not favorable for JNJ, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.

Profitability Analysis for NYSE:JNJ

ChartMill's Profitability Rating offers a unique perspective on stock analysis, providing scores from 0 to 10. These ratings consider a wide range of profitability metrics and margins, both in comparison to industry peers and on their own merits. For NYSE:JNJ, the assigned 7 is a significant indicator of profitability:

  • Looking at the Return On Assets, with a value of 20.85%, JNJ belongs to the top of the industry, outperforming 97.04% of the companies in the same industry.
  • JNJ's Return On Equity of 48.61% is amongst the best of the industry. JNJ outperforms 96.55% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 17.33%, JNJ belongs to the top of the industry, outperforming 94.09% of the companies in the same industry.
  • JNJ has a better Profit Margin (39.58%) than 98.03% of its industry peers.
  • JNJ's Profit Margin has improved in the last couple of years.
  • With an excellent Operating Margin value of 28.66%, JNJ belongs to the best of the industry, outperforming 94.58% of the companies in the same industry.
  • JNJ's Gross Margin of 68.86% is fine compared to the rest of the industry. JNJ outperforms 75.37% of its industry peers.

Our Best Dividend screener lists more Best Dividend stocks and is updated daily.

Our latest full fundamental report of JNJ contains the most current fundamental analsysis.

Keep in mind

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.

Back

JOHNSON & JOHNSON

NYSE:JNJ (4/19/2024, 7:04:00 PM)

After market: 147.89 -0.02 (-0.01%)

147.91

+2.17 (+1.49%)

JNJ News

News Imagean hour ago - InvestorPlaceInvesting for the Long-Term: 3 Stocks With Proven Track Records

As uncertainty in the global economy and geopolitical climate abounds, investors should focus on stocks with proven track records.

News Image16 hours ago - Market News VideoNoteworthy Friday Option Activity: PSFE, GEO, JNJ
News Image17 hours ago - InvestorPlaceThese 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?

Small-cap stocks have been the market laggards but these standouts showed how to beat even top-tier tech names at their own game.

News Image19 hours ago - Investor's Business DailyStock Market Sells Off; Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review

The Nasdaq and S&P 500 tumbled below their 50-day lines.

News Image21 hours ago - Yahoo FinanceAnalyst updates Johnson & Johnson stock price target after earnings

This is what could happen next to Johnson & Johnson shares.

News Imagea day ago - Zacks Investment ResearchThe Zacks Analyst Blog Highlights NVIDIA, Alphabet, Johnson & Johnson, Broadridge Financial and Textron

NVIDIA, Alphabet, Johnson & Johnson, Broadridge Financial and Textron are included in this Analyst Blog.

News Image2 days ago - Yahoo FinanceJ&J wins trial over Florida woman who claimed its baby powder caused her cancer

A Florida jury on Thursday concluded that Johnson & Johnson's baby powder talc product did not cause the ovarian cancer of a Florida woman who died in 2019. The lawsuit was brought by family members of Patricia Matthey, a Sarasota County resident who used Johnson's baby powder daily from 1965 until August 2016, when she was diagnosed with ovarian cancer, according to her family's lawsuit. J&J's Worldwide Vice President of Litigation Erik Haas said the company was vindicated by the jury's decision.

News Image2 days ago - Zacks Investment ResearchTop Stock Reports for NVIDIA, Alphabet & Johnson & Johnson

Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Alphabet Inc. (GOOGL) and Johnson & Johnson (JNJ).

News Image2 days ago - InvestorPlaceRecession-Proof Riches: 3 Stocks That Thrive in Any Economy

Discover recession-proof stocks that thrive amid economic uncertainty, offering stability and consistent growth.

News Image2 days ago - InvestorPlaceWant to Double Your Tax Refund in 2024? 7 Stocks to Buy Now.

Investors wondering which tax refund stocks to invest in should consider these names, each of which is a capital compounder.

News Image16 days ago - ChartmillWondering what's happening in today's after-hours session with S&P500 stocks? Stay tuned for the latest updates on movers and shakers.

Top S&P500 movers in Thursday's after hours session

News Image16 days ago - ChartmillWhy NYSE:JNJ provides a good dividend, while having solid fundamentals.

Balancing Dividends and Fundamentals: The Case of JOHNSON & JOHNSON (NYSE:JNJ).

JNJ Links
Follow us for more